Knockdown of CYP24A1 Aggravates 1α,25(OH)2D3-Inhibited Migration and Invasion of Mouse Ovarian Epithelial Cells by Suppressing EMT
Ping Wang,Jiming Xu,Weijing You,Yongfeng Hou,Shuiliang Wang,Yujie Ma,Jianming Tan,Zengli Zhang,Wentao Hu,Bingyan Li
DOI: https://doi.org/10.3389/fonc.2020.01258
IF: 4.7
2020-07-29
Frontiers in Oncology
Abstract:Epithelial-mesenchymal transition (EMT) bestows cancer cells with motile and invasive properties. But for ovarian tissues, EMT plays a physiological role in the postovulatory repair of ovary surface epithelial (OSE) cells. Accumulating data indicated that 1α,25(OH)<sub>2</sub>D<sub>3</sub> decreased both the migration and invasion of various cancer cells by suppressing EMT. However, it remains unclear whether 1α,25(OH)<sub>2</sub>D<sub>3</sub> inhibits the process of EMT during different stages of oncogenic transformation in mouse OSE (MOSE) cells. In present study, a spontaneous malignant transformation model of MOSE cells at three sequential stages (early, intermediate and late) was established <i>in vitro</i> first and then subjected to 1α,25(OH)<sub>2</sub>D<sub>3</sub> treatment to investigate the effect of 1α,25(OH)<sub>2</sub>D<sub>3</sub> on the oncogenic transformation of MOSE cells. We found that 1α,25(OH)<sub>2</sub>D<sub>3</sub> significantly reduced the proliferation and invasion of late malignant transformed MOSE (M-L cells) cells by inhibiting EMT both <i>in vitro</i> and <i>in vivo</i>, but not in intermediate transformed (M-I) cells. Importantly, we found that the levels of CYP24A1 in M-I cells were dramatically higher than that in M-L cells following treatment with 1α,25(OH)<sub>2</sub>D<sub>3</sub>. Furthermore, we demonstrated that, in both M-I and M-L cells with CYP24A1 knockdown, 1α,25(OH)<sub>2</sub>D<sub>3</sub> suppressed the proliferation and invasion, and reduced the expression of N-cadherin, Vimentin, β-catenin and Snail. In addition, knockdown of CYP24A1 suppressed EMT by increasing E-cadherin while decreasing N-cadherin, Vimentin, β-catenin and Snail. These findings provide support for inhibiting CYP24A1 as a potential approach to activate the vitamin D pathway in the prevention and therapy of ovarian cancer.
oncology